CTGF Expression in Acute Lymphoblastic Leukaemia
Author Information
Author(s): Vorwerk P, Wex H, Hohmann B, Oh Y, Rosenfeld R G, Mittler U
Primary Institution: Otto von Guericke University Magdeburg
Hypothesis
The expression of CTGF (IGFBP-rP2) in human leukaemic lymphoblasts from children with acute lymphoblastic leukaemia (ALL) was investigated.
Conclusion
The study found that 61% of patients with ALL expressed CTGF, while control groups showed no expression.
Supporting Evidence
- 61% of patients with ALL expressed CTGF.
- No expression of CTGF was detected in control groups.
- Only 3.5% of adult CML patients were positive for CTGF.
Takeaway
The study looked at a protein called CTGF in kids with a type of blood cancer, and found that many of them had this protein, but healthy kids did not.
Methodology
RNA samples from tumor clones were studied using RT-PCR.
Limitations
The role of CTGF in leukaemogenesis and its potential as a tumor marker requires further evaluation.
Participant Demographics
107 children with ALL and 57 adults with chronic myeloid leukaemia (CML), along with control groups of children with IDDM and healthy newborns.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website